Brinzolamide

Name: Brinzolamide
Brand: Neuland Laboratories
SKU: 138890-62-7

Brinzolamide API is a carbonic anhydrase inhibitor that lowers intraocular pressure in the treatment of glaucoma and ocular hypertension preventing vision loss.

CAS Registry No.

138890-62-7

Molecule Type

Small Molecule

Therapeutic Segment

Antiglaucoma

Development Status

DMF Filed

Product Specifications

Active API

Product NameBrinzolamide

CAS Registry Number138890-62-7

Molecule TypeSmall Molecule

Therapeutic CategoryAntiglaucoma

Development StatusDMF Filed

Regulatory Filings

USDMFE-DMF

Molecular Structure

Click to Enlarge

Enquire Now

Mechanism of Action

Pharmacological Profile & Biological Activity

Brinzolamide is an inhibitor of carbonic anhydrase II and inhibits aqueous humor formation and reduces elevated IOP.

Disclaimer: No information in this Catalog – including any reference to any product or service – constitutes an offer for sale or be constructed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, under Bolar Provision the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of patent scenario for their respective markets and will be responsible for all patent related liabilities.